Subramanian Sriram

Title: Subramanian Sriram: Innovator in Autoimmune Disease Treatment

Introduction

Subramanian Sriram is a notable inventor based in Burlington, VT (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach has the potential to change the lives of many individuals suffering from these conditions.

Latest Patents

Sriram holds a patent for a method of treating autoimmune diseases that are mediated by Leu3/CD4. This patent addresses certain autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. The method involves in vivo treatment with a complement-fixing anti-Leu3 (CD4) antibody that is cytotoxic to Leu3 (CD4) phenotype T cells. This groundbreaking work has the potential to prevent or attenuate the effects of these debilitating diseases.

Career Highlights

Subramanian Sriram is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to improving patient outcomes through scientific discovery and application.

Collaborations

Sriram has collaborated with esteemed colleagues such as Matthew K Waldor and Lawrence Steinman. These partnerships have fostered a rich environment for innovation and have contributed to the advancement of research in autoimmune diseases.

Conclusion

Subramanian Sriram's contributions to the treatment of autoimmune diseases highlight his role as a leading inventor in the medical field. His innovative methods and collaborations with other experts underscore the importance of research in developing effective treatments.